Ján Gaspar

Title: Ján Gaspar: Innovator in Pharmaceutical Purification

Introduction

Ján Gaspar is a notable inventor based in Bratislava-Dúbravka, Slovakia. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of important compounds. His work has implications for the production of high-purity medications, which are essential for effective treatment.

Latest Patents

Ján Gaspar holds a patent for a method for isolation and purification of naltrexone. This invention describes a method for purifying naltrexone base from reaction mixtures concentrated by evaporation and/or from mixtures containing naltrexone in the presence of other organic or inorganic substances. The process involves trituration and/or extraction and crystallization from cyclopentyl methyl ether (CPME), optionally from a mixture of CPME and another organic solvent. The method results in naltrexone of high purity, which can be utilized in a parenteral dosage form.

Career Highlights

Gaspar is currently employed at Saneca Pharmaceuticals a.s., where he applies his expertise in pharmaceutical development. His innovative approach to purification processes has positioned him as a valuable asset in the industry. His work not only enhances the quality of pharmaceutical products but also contributes to the overall efficiency of drug manufacturing.

Collaborations

Ján Gaspar collaborates with several professionals in his field, including Miroslav Kavala and Dusan Vandák. These partnerships foster a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ján Gaspar's contributions to the pharmaceutical industry through his patent for the purification of naltrexone exemplify the importance of innovation in medicine. His work continues to impact the field positively, ensuring that high-quality medications are available for patients in need.